Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Recruiting

Phase 2

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following AbdominoplastyEvaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Sponsor:

Teikoku Pharma USA, Inc.

Code:

NCT05412992

Conditions

Pain, Postoperative

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DMTS Patch

Placebo Patch

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Teikoku Pharma USA, Inc. on 2022-08-02.